Home » Newsletters » BioWorld Science

BioWorld Science

May 15, 2002

View Archived Issues

LidoPAIN BP effective and safe for acute lower back pain

Recent launch of new COX-2 inhibitor for acute and chronic painful conditions

U.K. launch for synthetic pentasaccharide for reducing the risk of venous thromboembolism

Broad-spectrum anticonvulsant and neuroprotective effects described for AMPA antagonist

Biochemical profile of the selective dopamine D4 receptor antagonist PD-89211

New noninvasive gene therapy approach to the treatment of osteosarcoma lung metastases

SkyePharma transfers E.U. Solaraze rights to Shire, acquires Bioglan's drug delivery business

Data analysis begins in two of aaiPharma's phase III trials for ProSorb-D

Ibandronate reduces fracture risk in postmenopausal women on different dosing regimens

Preliminary results of DAC:Opioid repeat-dose trial

AGI-1096 decreases preclinical graft narrowing associated with transplant rejection

SPP-301 enters phase II testing

CA 19-9 Radioimmunoassay approved for monitoring of pancreatic cancer

Dyax and AstraZeneca collaborate on antibody discovery and optimization

Fast track designation for Tarceva in chemotherapy-naive NSCLC

Abgenix and Corvas collaborate on therapeutic antibody development for cancer

MacroGenics licenses therapeutic target for Epstein-Barr virus

IND cleared for LymphoRad to enter phase I studies

Novel antifungal agents produced in microorganism cultures

Indazoles with thyroid hormone-like activity and their use

AstraZeneca designs new cell proliferation inhibitors targeting CDKs

New inhibitors of PDGF receptor kinase useful in cancer and other proliferative diseases

Roche presents quinoline and quinazoline NPY receptor antagonists

Japanese labs identify new antiglaucoma agents

F-15603: a new antitumor compound with apoptosis-inducing activity in p53-deficient cells

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...